KeyCorp Comments on Medical Properties Trust, Inc.’s Q1 2020 Earnings (NYSE:MPW)

Share on StockTwits

Medical Properties Trust, Inc. (NYSE:MPW) – Analysts at KeyCorp issued their Q1 2020 earnings per share (EPS) estimates for Medical Properties Trust in a report issued on Monday, February 10th. KeyCorp analyst J. Sadler anticipates that the real estate investment trust will post earnings of $0.40 per share for the quarter. KeyCorp has a “Overweight” rating and a $23.00 price target on the stock. KeyCorp also issued estimates for Medical Properties Trust’s Q2 2020 earnings at $0.42 EPS, Q3 2020 earnings at $0.42 EPS, Q4 2020 earnings at $0.42 EPS, FY2020 earnings at $1.67 EPS and FY2021 earnings at $1.75 EPS.

Medical Properties Trust (NYSE:MPW) last released its quarterly earnings results on Thursday, February 6th. The real estate investment trust reported $0.26 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.35 by ($0.09). Medical Properties Trust had a return on equity of 6.57% and a net margin of 43.86%. The business had revenue of $256.44 million during the quarter, compared to analyst estimates of $263.35 million. During the same quarter last year, the firm posted $0.31 EPS. The company’s revenue was up 42.0% compared to the same quarter last year.

MPW has been the topic of several other research reports. Zacks Investment Research upgraded Medical Properties Trust from a “hold” rating to a “buy” rating and set a $24.00 price target on the stock in a research note on Wednesday, January 8th. Robert W. Baird boosted their price objective on Medical Properties Trust from $20.00 to $22.00 and gave the company a “neutral” rating in a report on Tuesday, January 14th. Barclays set a $22.00 price objective on Medical Properties Trust and gave the company a “buy” rating in a report on Monday, October 21st. Mizuho boosted their price objective on Medical Properties Trust from $25.00 to $26.00 and gave the company a “buy” rating in a report on Thursday, December 26th. Finally, ValuEngine raised Medical Properties Trust from a “sell” rating to a “hold” rating in a report on Tuesday, December 3rd. Three analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $21.59.

NYSE:MPW opened at $24.08 on Thursday. The company has a debt-to-equity ratio of 1.00, a quick ratio of 6.27 and a current ratio of 9.45. Medical Properties Trust has a one year low of $16.83 and a one year high of $24.09. The business’s 50-day simple moving average is $22.05 and its 200 day simple moving average is $20.14. The stock has a market cap of $12.33 billion, a price-to-earnings ratio of 28.00, a price-to-earnings-growth ratio of 3.20 and a beta of 0.58.

Several large investors have recently bought and sold shares of MPW. BlackRock Inc. grew its holdings in Medical Properties Trust by 1.6% in the 2nd quarter. BlackRock Inc. now owns 45,070,249 shares of the real estate investment trust’s stock worth $786,026,000 after buying an additional 702,061 shares in the last quarter. Cohen & Steers Inc. grew its holdings in Medical Properties Trust by 35.5% in the 4th quarter. Cohen & Steers Inc. now owns 31,725,541 shares of the real estate investment trust’s stock worth $669,726,000 after buying an additional 8,316,576 shares in the last quarter. State Street Corp grew its holdings in Medical Properties Trust by 23.5% in the 4th quarter. State Street Corp now owns 22,999,468 shares of the real estate investment trust’s stock worth $491,555,000 after buying an additional 4,377,804 shares in the last quarter. Bank of New York Mellon Corp grew its holdings in Medical Properties Trust by 4.4% in the 4th quarter. Bank of New York Mellon Corp now owns 14,581,205 shares of the real estate investment trust’s stock worth $307,810,000 after buying an additional 612,306 shares in the last quarter. Finally, Daiwa Securities Group Inc. grew its holdings in Medical Properties Trust by 10.1% in the 4th quarter. Daiwa Securities Group Inc. now owns 7,750,447 shares of the real estate investment trust’s stock worth $163,612,000 after buying an additional 708,443 shares in the last quarter. 72.14% of the stock is owned by institutional investors.

In other news, Director Michael G. Stewart sold 4,800 shares of the company’s stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $21.27, for a total transaction of $102,096.00. Also, COO Emmett E. Mclean sold 100,000 shares of the company’s stock in a transaction that occurred on Wednesday, January 8th. The shares were sold at an average price of $20.84, for a total value of $2,084,000.00. Following the transaction, the chief operating officer now directly owns 1,003,415 shares of the company’s stock, valued at $20,911,168.60. The disclosure for this sale can be found here. 1.18% of the stock is owned by insiders.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

Read More: Do You Need a Fiduciary?

Earnings History and Estimates for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Riot Blockchain Inc  Given $3.50 Average Target Price by Brokerages
Riot Blockchain Inc Given $3.50 Average Target Price by Brokerages
Todd Pendleton Sells 60,958 Shares of Dolby Laboratories, Inc.  Stock
Todd Pendleton Sells 60,958 Shares of Dolby Laboratories, Inc. Stock
Jeffrey A. Wilke Sells 3,475 Shares of Amazon.com, Inc.  Stock
Jeffrey A. Wilke Sells 3,475 Shares of Amazon.com, Inc. Stock
Insider Selling: Kinder Morgan Inc  Director Sells 309,370 Shares of Stock
Insider Selling: Kinder Morgan Inc Director Sells 309,370 Shares of Stock
Insider Selling: Cadence Design Systems Inc  VP Sells 60,000 Shares of Stock
Insider Selling: Cadence Design Systems Inc VP Sells 60,000 Shares of Stock
C James Koch Sells 10,000 Shares of Boston Beer Company Inc  Stock
C James Koch Sells 10,000 Shares of Boston Beer Company Inc Stock


 
© 2006-2020 Zolmax.